luced test Archives

VisionGate protocol shows promise, pulmonologists say

VisionGate

Two recent surveys conducted by an independent, third-party research group validated the market demand for VisionGate’s LuCED test as well as its recently licensed drug therapy, Iloprost, in the diagnosis and treatment of patients at risk of lung cancer. LuCED, represented as “Product X” in surveys among 100 pulmonologists, is a non-invasive test to aid… Read More →

VisionGate Uses 3D Imaging To Detect Lung Cancer

VisionGate, 3D Cellular Imaging - AZ Business Magazine September/October 2011

In September 2010, the City of Phoenix, in partnership with VisionGate, opened the world’s first biomedical 3D cellular imaging lab. The Cell-CT research lab is located on the Phoenix Biomedical Campus in downtown Phoenix. A year later, VisionGate is well on its way to developing a revolutionary non-invasive test for the early detection of lung… Read More →